*|MC:SUBJECT|*
BioRN News February 2022
View this email in your browser

Dear *|FNAME|* *|LNAME|*,


Spring and Summer are getting crowded with events and conferences back on-site. At BioRN as well, we are on light-speed preparing an excellent Agenda for the traditional BioRN Annual Conference. It will take place at the end of September/beginning of October and will adress "Molecular Mechanism for Ageing and Longevity". Do you have ideas about it? Contact us and stay tune for the save-the-date coming up in few weeks.

Our Lounges 2022 kicked off this week Heidelberg and we kindly invite you to join the next one on March 29 at 7 pm, where Prof. Wolfgang Wick will talk about the "Evolution of the Heidelberg Mannheim Health & Life Science Alliance” [more]

CALL for Startups: AbbVie is currently granting a Golden Ticket for early-stage biotech company, including the opportunity for residence in Biolabs Heidelberg. Do not miss this unique opportunity!

And finally, in case you have missed one of my previous email, you can download it here our BioRN Events Calendar. Sync it with yours!

Enjoy the read!
 
Annalisa Zuccotti
Events & Communication Lead
BioRN Life Science Cluster Rhine-Neckar
01 | Research Highlights & News
02 | New BioRN Members
03 | BioRN Lounge
04 | Funding - Research Grants
05 | Event Calendar & Discounts
06 | Open Positions
01| Research Highlights & News


Affimed Publishes Preclinical Data Demonstrating Cytotoxic Potency and Efficacy of NK Cells [more]

AGC Biologics Supports BioNTech Omicron-based Vaccine Candidate with pDNA Starting Material [more]

AION Labs, Powered by BioMed X, Launches Third Global Call for Application: Artificial Intelligence for Design and Optimization of Antibodies for Targeted Therapies [more]

BioMed X and Merck KGaA extend collaboration in oncology [more]

EMBL:
  • EMBL and Latvia deepen collaboration [more]
  • Learning from Deep Learning: the inspirational story behind AlphaFold [more]
Germany and France intend to commit €1 billion each for new European Tech Champions Initiative [more]

Heidelberg Pharma First Patient Dosed with Antibody Targeted Amanitin Conjugate HDP-101 in Multiple Myeloma [more]

Heidelberg University:
  • Strong Subjects in the THE Ranking by Subject [more]
  • Antibody Study Highlights Heidelberg Myeloma Agenda [more]
Novaliq: Dermaliq Therapeutics Signs USD 15 Million Series A Round [more]
 

02 | New BioRN Members

For over 15 years, Amazon Web Services has been the world’s most comprehensive and broadly adopted cloud platform. Trusted by thousand of healthcare and life sciences customers around the world – including the fastest-growing startups, the largest enterprises, and the leading government agencies. AWS offers secure and compliant solutions to keep protected health information (PHI) private enabling the highly regulated healthcare and life sciences industry to increase the pace of innovation, unlock the potential of data, improve clinical and operational efficiency, and personalized the healthcare journey, improving the healthcare experience and ultimately patient outcomes.
Fluidigm develops, manufactures, and markets research products for life science analytical and preparatory systems for use in high dimensional cytometry, spatial biology, high-throughput genomics, and single cell genomics applications. Fluidigm sells to leading academic institutions, clinical research laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology companies worldwide.

03 | BioRN Lounge


BioRN Lounge

On March 29 at 7 pm
„Evolution of the Heidelberg Mannheim Health & Life Science Alliance”
 

with Wolfgang Wick
University Clinic Heidelberg - Neurology


Back in Heidelberg!

Register here!

04 | Funding - Research Grants & Prizes


33rd CORNET CAll for Proposals - Funding for SMEs  [more]
BMBF - Alternative methods to animal testing [more]
BMBF - Computational Life Sciences - AI methods for medicine  [more]
EU4Health 2021-2027 - a vision for a healthier Europe [more]
European Innovation Council EIC launched:
Health-i Award 2022 [more]
Horizon Europe 2021-22 Overview [more]
Innovationspreis 2022 der BioRegionen in Deutschland [more]
IraSME call for proposals for transnational R&D projects [more]
Merck research challenges [more]

 

05 | Event Calendar & Discounts

J&J Innovation: Recruitment - Building Your Team as the Foundation of Success
March 3, 2022 - digital >>
 

FEMTECH FIGURES by NEXT Mannheim
March 8, 2022 - MAFINEX Technology Center, Mannheim >>
 
J&J Innovation: The Ins and Outs of Outsourcing for Startups
March 10, 2022 - digital >>
 


GenScript: CRISPR goes viral - Workshop
March 17, 2022 - digital >>
 

Evotec Webinar: AAV gene tehrapy - closing the translational gap
March 23, 2022 - digital >>
 

Soforthilfe made in THE LÄND - Baden-Württembergs Unterstützung für die Medizintechnikbranche
March 24, 2022 - digital >>
 
Workshop: Engineering Molecular Systems for Medical Applications
March 31, 2022 - digital >>
 

17. Heidelberger KrebsPatiententag
April 2, 2022 digital >>
 
BioTrinity 2022
April 26-27, 2022 - London, UK
BioRN members receive a 10% discount on ticket prices by following this link >>

 

Swiss Biotech Day 2022
May 2-3, 2022 - Basel, Switzerland
BioRN members can benefit from a reduced ticket price >>

 

CONTACT2022 - Life Science Job Fair
May 4, 2022 - German Cancer Research Center Heidelberg >>
 

BioVaria 2022
May 11-12, 2022 - Munich, Germany & digital >>
 

Chromatography modeling days
May 23-25, 2022 - Heidelberg, Germany >>
 

Curious 2022 - Future Insight Conference
July 12-14, 2022 - Merck KGaA, Darmstadt, Germany >>
 

06 | Open Positions


Affimed: Director of Regulatory Affairs (f/m/d) in Heidelberg [more]

AION Labs:  
  • Group Leader / Scientist Founder (all genders) [more]
  • 2 Postdoctoral Researchers / Scientist Co-Founders (all genders) [more]
BioMed X:
  • Postdoctoral Position (all genders) in Optics / Physics – Group Biomarker Detection in Brain [more]
  • Research Assistant Position (all genders) Synthetic Lethality in DNA Repair (SDR) [more]
  • Life Science Recruiting & Communications Manager (all genders) [more]
Cellzome / GSK:  
  • Senior Scientist Chemoproteomics (m/w/d) in Heidelberg [more]
  • Computational Biologist: Translational Oncology (m/f/d) in Heidelberg [more]
PEPperPRINT: Immunologe / Biologe / Biochemiker (m/w/d) in Heidelberg [more]

PROGEN: Mitarbeiter/in in der Qualitätskontrolle (m/w/d) in Heidelberg [more]

Singleron:  Project Manager – Single Cell Sequencing in Cologne [more]

Vector Builder: Territory Manager (DACH Region) in Frankfurt [more]
 
Tweet
Forward
Share

Imprint


Copyright © *|CURRENT_YEAR|* *|LIST:COMPANY|*, All rights reserved.
*|IFNOT:ARCHIVE_PAGE|* *|LIST:DESCRIPTION|*

Responsible for the content:
Dr. Julia Schaft

Editor: Dr. Annalisa Zuccotti

Our mailing address is:
*|HTML:LIST_ADDRESS_HTML|* *|END:IF|*

Commercial Register: Mannheim, HRB 704801
VAT ID: DE 2630 64 014

unsubscribe from this list    update subscription preferences 

*|IF:REWARDS|* *|HTML:REWARDS|* *|END:IF|*